Affiliations: Medicina Nucleare e Radiodiagnostica, Istituto Nazionale dei Tumori, Naples, Italy
via Raffaele De Cesare 7, Naples 80132, Italy
Ctr. Med. Nucl. Cons. Naz. Ric., Univ. degli Studi Federico II, Naples, Italy
References: Not available.
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions
OBJECTIVE: The aim of this study was to differentiate benign from malignant adrenal tumors using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with unilateral adrenal masses originally detected by CT or MR imaging. CONCLUSION: PET imaging with FDG can metabolically characterize adrenal masses. Abnormally increased FDG uptake in adrenal malignancies allows one to differentiate these abnormalities from benign lesions. Whole-body PET can also reveal extraadrenal tumor sites in patients with malignant tumors, using a single imaging technique for accurate disease staging.
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions
No results.
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions